Home / News Update  / CVS, Walgreens say they’ll start dispensing abortion pill mifepristone

CVS, Walgreens say they’ll start dispensing abortion pill mifepristone

CVS and Walgreens said they’ve received certification to dispense mifepristone, a pill that’s part of a regimen for medication abortion, and will start making the medicine available in a limited number of states where it’s

CVS and Walgreens said they’ve received certification to dispense mifepristone, a pill that’s part of a regimen for medication abortion, and will start making the medicine available in a limited number of states where it’s legal.

CVS told CNN that it’ll begin filling prescriptions for mifepristone in Massachusetts and Rhode Island “in the weeks ahead” and plans to expand to more states, on a rolling basis.”

Walgreens told CNN that it expects to start dispensing mifepristone within a week, in New York, Pennsylvania, Massachusetts, California and Illinois. The pharmacy giant said it’s starting with a phased rollout “to allow us to ensure quality, safety and privacy for our patients, providers and team members.”
Both pharmacy chains noted that they already dispense misoprostol, the other medication involved in medication abortion regimens.

Medication abortion is the most common method of abortion in the United States, according to data from the US Centers for Disease Control and Prevention. It’s approved by the US Food and Drug Administration for use up to 10 weeks into pregnancy.

Mifepristone has been at the center of legal challenges in the US, and the Supreme Court said in December that it would consider whether to restrict access to it, with a decision expected by July.

The New York Times first reported Friday that CVS and Walgreens plan to sell mifepristone.

The FDA issued an update to guidelines around how mifepristone may be dispensed in January 2023, allowing the drug to be provided by “certified pharmacies on a prescription issued by a doctor”

Before then, the FDA required certified prescribers to dispense the drug directly to patients at a clinic, medical office or hospital, referred to as the “in-person dispensing requirement.”

President Joe Biden called the news “an important milestone in ensuring access to mifepristone, a drug that has been approved by the Food and Drug Administration as safe and effective for more than 20 years.”

Biden also warned that the stakes “could not be higher for women across America” and vowed that “in the face of relentless attacks on reproductive freedom by Republican elected officials,” his administration would work to restore the protections of Roe v. Wade.

The Biden campaign has sought to make abortion and contraception access a main platform of the 2024 campaign, deploying Vice President Kamala Harris on a reproductive freedoms tour across the country.

medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT